RadNet, Inc. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
RadNet, Inc. (RDNT) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $10.56 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-10
- RadNet, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $10.56M, a 20.51% increase year-over-year.
- RadNet, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $31.44M, a 10.26% increase year-over-year.
- RadNet, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-12-31 was $8.37M, a 2.47% decline year-over-year.
- RadNet, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $9.19M, a 94.44% increase year-over-year.
- RadNet, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $54.83M, a 82.87% increase from fiscal 2024.
- RadNet, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $29.99M, a 11.95% increase from fiscal 2023.
- RadNet, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $26.79M, a 13.77% increase from fiscal 2022.
- RadNet, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $23.54M, a 6.89% decline from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $10.56M 10-Q · filed 2026-08-10 | $42.00M 10-Q · filed 2026-08-10 | $50.37M derived: sum of 3 quarters · filed 2026-08-10 | $59.56M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $31.44M 10-Q · filed 2026-05-11 | $39.81M derived: sum of 2 quarters · filed 2026-05-11 | $49.00M derived: sum of 3 quarters · filed 2026-05-11 | $57.76M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $8.37M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $17.56M derived: sum of 2 quarters · filed 2026-03-02 | $26.32M derived: sum of 3 quarters · filed 2026-08-10 | $54.83M 10-K · filed 2026-03-02 |
| 2025-09-30 | $9.19M 10-Q · filed 2025-11-10 | $17.95M derived: sum of 2 quarters · filed 2026-08-10 | $46.47M 10-Q · filed 2025-11-10 | $55.05M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $8.76M 10-Q · filed 2026-08-10 | $37.27M 10-Q · filed 2026-08-10 | $45.85M derived: sum of 3 quarters · filed 2026-08-10 | $50.58M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $28.51M 10-Q · filed 2026-05-11 | $37.09M derived: sum of 2 quarters · filed 2026-05-11 | $41.82M derived: sum of 3 quarters · filed 2026-05-11 | $46.59M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $8.58M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $13.31M derived: sum of 2 quarters · filed 2026-03-02 | $18.08M derived: sum of 3 quarters · filed 2026-03-02 | $29.99M 10-K · filed 2026-03-02 |
| 2024-09-30 | $4.73M 10-Q · filed 2025-11-10 | $9.50M derived: sum of 2 quarters · filed 2025-11-10 | $21.41M 10-Q · filed 2025-11-10 | $26.81M derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-06-30 | $4.77M 10-Q · filed 2025-08-11 | $16.68M 10-Q · filed 2025-08-11 | $22.08M derived: sum of 3 quarters · filed 2026-03-02 | $26.41M derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-03-31 | $11.91M 10-Q · filed 2025-05-12 | $17.31M derived: sum of 2 quarters · filed 2026-03-02 | $21.64M derived: sum of 3 quarters · filed 2026-03-02 | $26.51M derived: sum of 4 quarters · filed 2026-03-02 |
| 2023-12-31 | $5.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $9.73M derived: sum of 2 quarters · filed 2026-03-02 | $14.60M derived: sum of 3 quarters · filed 2026-03-02 | $26.79M 10-K · filed 2026-03-02 |
| 2023-09-30 | $4.33M 10-Q · filed 2024-11-12 | $9.20M derived: sum of 2 quarters · filed 2024-11-12 | $21.38M 10-Q · filed 2024-11-12 | $26.07M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | $4.87M 10-Q · filed 2024-08-09 | $17.05M 10-Q · filed 2024-08-09 | $21.74M derived: sum of 3 quarters · filed 2025-03-03 | $25.10M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | $12.19M 10-Q · filed 2024-05-10 | $16.87M derived: sum of 2 quarters · filed 2025-03-03 | $20.23M derived: sum of 3 quarters · filed 2025-03-03 | $24.93M derived: sum of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | $4.69M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $8.05M derived: sum of 2 quarters · filed 2025-03-03 | $12.74M derived: sum of 3 quarters · filed 2025-03-03 | $23.54M 10-K · filed 2025-03-03 |
| 2022-09-30 | $3.36M 10-Q · filed 2023-11-09 | $8.05M derived: sum of 2 quarters · filed 2023-11-09 | $18.86M 10-Q · filed 2023-11-09 | $22.53M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $4.69M 10-Q · filed 2023-08-09 | $15.49M 10-Q · filed 2023-08-09 | $19.17M derived: sum of 3 quarters · filed 2024-02-29 | $23.63M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $10.80M 10-Q · filed 2023-05-10 | $14.48M derived: sum of 2 quarters · filed 2024-02-29 | $18.94M derived: sum of 3 quarters · filed 2024-02-29 | $27.84M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $3.68M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $8.14M derived: sum of 2 quarters · filed 2024-02-29 | $17.04M derived: sum of 3 quarters · filed 2024-02-29 | $25.28M 10-K · filed 2024-02-29 |
| 2021-09-30 | $4.46M 10-Q · filed 2022-11-09 | $13.36M derived: sum of 2 quarters · filed 2022-11-09 | $21.61M 10-Q · filed 2022-11-09 | $23.87M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $8.90M 10-Q · filed 2022-08-09 | $17.14M 10-Q · filed 2022-08-09 | $19.41M derived: sum of 3 quarters · filed 2023-03-01 | $21.47M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $8.25M 10-Q · filed 2022-05-10 | $10.51M derived: sum of 2 quarters · filed 2023-03-01 | $12.57M derived: sum of 3 quarters · filed 2023-03-01 | $14.12M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $2.26M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $4.33M derived: sum of 2 quarters · filed 2023-03-01 | $5.87M derived: sum of 3 quarters · filed 2023-03-01 | $12.46M 10-K · filed 2023-03-01 |
| 2020-09-30 | $2.07M 10-Q · filed 2021-11-09 | $3.61M derived: sum of 2 quarters · filed 2021-11-09 | $10.20M 10-Q · filed 2021-11-09 | |
| 2020-06-30 | $1.54M 10-Q · filed 2021-08-09 | $8.14M 10-Q · filed 2021-08-09 | ||
| 2020-03-31 | $6.60M 10-Q · filed 2021-05-10 | |||
| 2019-09-30 | $1.36M 10-Q · filed 2020-11-09 | $2.48M derived: sum of 2 quarters · filed 2020-11-09 | $6.99M 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $1.12M 10-Q · filed 2020-08-10 | $5.64M 10-Q · filed 2020-08-10 | ||
| 2018-09-30 | $1.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $2.62M derived: sum of 2 quarters · filed 2018-11-09 | $6.26M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $1.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $4.70M 10-Q · filed 2018-08-09 | ||
| 2018-03-31 | $3.64M 10-Q · filed 2018-05-10 | |||
| 2017-09-30 | $918.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $5.03M 10-Q · filed 2017-11-09 | ||
| 2017-06-30 | $4.11M 10-Q · filed 2017-08-09 | |||
| 2016-09-30 | $1.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $4.66M 10-Q · filed 2016-11-09 | ||
| 2016-06-30 | $3.61M 10-Q · filed 2016-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |